MedPath

LENVIMA

LENVIMA

Approved
DIN Number

02484056

Drug Class

Human

Market Date

Oct 21, 2019

Company
HC

EISAI LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02484056
AIG Number0157671007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX08 LENVATINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LENVATINIB (LENVATINIB MESYLATE)Active
Strength: 4 MG / DOSE
Monograph: LENVATINIB (LENVATINIB MESYLATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.